Digest Network Come funziona
Network
/
Società
Co
Non verificato

CorriXR Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaOncologiaSaluteScienza

7 comunicati stampa

Guarda tutti i comunicati
02/12/2025
Mercato del lavoro
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/12/2025
Mercato del lavoro
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
19/08/2025
CorriXR Therapeutics Secures $1M Investment from State of Delaware
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/01/2025
CorriXR Therapeutics Appoints Jan Case as Chief Operating Officer
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
10/12/2024
Multimedialità
Mercato del lavoro
Scienza
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/09/2024
CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors
Fonte
CorriXR Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0